Global Micro-Invasive Glaucoma Implants Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

미세 침습성 녹내장 임플란트 시장 분석

미세 침습성 녹내장 임플란트 시장은 녹내장 유병률 증가와 최소 침습 수술 옵션에 대한 수요 증가로 인해 상당한 성장을 경험하고 있습니다. 미세 침습성 녹내장 임플란트는 최소한의 조직 파괴로 제어된 안구 내압 감소를 제공하여 효과적인 치료 솔루션을 제공합니다. 이 시장의 최근 개발에는 눈의 배수 시스템에서 유출을 개선하는 능력에 대해 FDA 승인을 받은 Hydrus Micro-Stent와 최소 침습성 녹내장 수술(MIGS)에서 새로운 기술을 개척하고 있는 Glaukos Corporation과 같은 회사의 발전이 포함됩니다. 시장의 확장은 의료 투자 증가와 외래 환자 시술로의 전환으로 더욱 뒷받침됩니다. 더 많은 환자가 기존 녹내장 수술보다 덜 침습적인 대안을 찾으면서 안전성, 효능 및 회복 시간 단축의 이점에 힘입어 미세 침습성 임플란트 채택이 증가할 것으로 예상됩니다. 이러한 추세는 시장의 역동적인 성장과 녹내장 관리 기술의 지속적인 혁신을 강조합니다.

미세 침습성 녹내장 임플란트 시장 규모

글로벌 미세 침습성 녹내장 임플란트 시장 규모는 2023년에 3억 1,819만 달러로 평가되었으며, 2031년까지 26억 1,166만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 30.10%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

미세 침습성 녹내장 임플란트 시장 동향

“ 최소 침습 수술 기술의 채택 증가”

글로벌 미세 침습성 녹내장 임플란트 시장은 녹내장 유병률 증가와 덜 침습적인 치료 옵션에 대한 수요의 영향으로 상당한 성장을 경험하고 있습니다. 시장에서 주목할 만한 추세는 최소 침습 수술 기술의 채택이 증가하고 있다는 것입니다. 최소 침습 수술 기술은 기존 시술에 비해 합병증 위험이 낮고 회복 시간이 빠르기 때문에 인기를 얻고 있습니다. 예를 들어, iSTAR Medical에서 출시한 혁신적인 장치인 Hydrus Micro-Stent는 미세 침습적 접근 방식으로 효과적인 안압 제어를 제공함으로써 이러한 추세를 잘 보여줍니다. 이러한 발전은 치료 패러다임을 재편하고 환자에게 상태를 관리하기 위한 보다 효율적이고 편안한 솔루션을 제공합니다. 그 결과, 시장은 빠르게 확장되고 있으며, 주요 업체는 보다 안전하고 효과적인 녹내장 치료에 대한 증가하는 수요를 충족하는 최첨단 임플란트 개발에 주력하고 있습니다.

보고 범위 및 미세 침습성 녹내장 임플란트 시장 세분화         

Micro-Invasive Glaucoma Implants Market Definition

Micro-invasive glaucoma implants are small, advanced medical devices designed to treat glaucoma through minimally invasive surgical techniques. These implants work by enhancing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure (IOP) more effectively than traditional methods. They are inserted into the eye's drainage system using tiny incisions, offering a less invasive alternative to conventional glaucoma surgeries. The primary goal of these implants is to manage IOP with minimal disruption to surrounding tissues, promoting quicker recovery and reducing the risk of complications.

Micro-Invasive Glaucoma Implants Market Dynamics

Drivers

• Increasing Prevalence of Glaucoma

The increasing prevalence of glaucoma is a significant driver for the global micro-invasive glaucoma implants market. Glaucoma, a leading cause of blindness, affects over 70 million people worldwide, according to the World Health Organization. Such high incidence of glaucoma necessitates effective and advanced treatment options to manage intraocular pressure (IOP) and prevent vision loss. As traditional treatment methods may not always suffice, there is a growing demand for innovative solutions such as micro-invasive glaucoma implants. These implants provide a less invasive approach to controlling IOP, offering patients an effective alternative with fewer complications and faster recovery times. Consequently, the surge in glaucoma cases directly fuels the market for micro-invasive implants, as healthcare providers seek to meet the increasing demand for advanced, minimally invasive treatment options to improve patient outcomes and quality of life.

• Rising Geriatric Population

The rising geriatric population is a significant driver for the global micro-invasive glaucoma implants market. As the global population ages, the prevalence of age-related eye conditions, including glaucoma, is increasing. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion. Such demographic shift results in a higher incidence of glaucoma, which is more common among older adults. For instance, the American Academy of Ophthalmology reports that People in their 70s have a 3 to 8 times higher prevalence of primary open-angle glaucoma (POAG), highlighting the growing need for effective treatment options. Micro-invasive glaucoma implants offer a minimally invasive approach to managing intraocular pressure (IOP) with fewer complications compared to traditional surgical methods. This makes them particularly appealing for elderly patients who may face higher risks with more invasive procedures. As the geriatric population expands, the demand for advanced, patient-friendly glaucoma treatments, such as micro-invasive implants, is anticipated to grow, driving market expansion.

Opportunities

• Expanding Global Healthcare Infrastructure Investments

The expansion of global healthcare infrastructure offers substantial opportunities for the micro-invasive glaucoma implants market. Increased investments in healthcare facilities are enhancing the availability of advanced medical technologies and improving access to specialized treatments. For instance, the World Bank's data indicates that global health expenditure has been growing steadily, with many countries allocating significant portions of their budgets to upgrade healthcare infrastructure. In regions such as Southeast Asia and Latin America, new hospitals and specialized eye care centers are being established, which support the integration of advanced glaucoma treatments. . As healthcare systems evolve, the increased availability and adoption of micro-invasive glaucoma implants become more feasible, thus driving market growth and enhancing patient access to innovative treatment options.

• Increasing Disposable Income Amog Individuals

The surge in disposable income among individuals presents a substantial opportunity for the global micro-invasive glaucoma implants market. As disposable income increases, particularly in emerging economies, consumers are more likely to invest in advanced healthcare solutions, including micro-invasive glaucoma implants. For instance, data from the World Bank indicates that global GDP per capita increased by 6.5% between 2020 and 2023, reflecting a rise in disposable income across many regions. Such financial uplift allows patients to afford innovative treatments that were previously out of reach.  As individuals gain greater financial flexibility, they are increasingly willing to opt for minimally invasive procedures that offer quicker recovery and better outcomes, thus expanding the market for these advanced glaucoma treatments.

Restraints/Challenges

• Shortage of Skilled and Trained Professionals

Global micro-invasive glaucoma implants market is facing challenge regarding the shortage of skilled and trained professionals. The intricacies of micro-invasive glaucoma surgery (MIGS) require a high level of expertise in both advanced surgical techniques and the application of specialized implants. The Ophthalmology Journal reports a projected 30% shortfall in ophthalmologist full-time equivalents (FTEs) by 2035 compared to demand. Such shortage of qualified professionals and technicians affects the effective use and deployment of micro-invasive implants, impeding market growth.

• High Cost of Advanced Micro-Invasive Glaucoma Implants

The high cost of advanced micro-invasive glaucoma Implants poses a significant challenge in the global market, particularly for products incorporating antimicrobial properties or cutting-edge materials. These advanced dressings, designed to enhance wound healing and prevent infections, often come with a higher price tag due to the sophisticated technologies and materials involved. For instance, antimicrobial dressings that contain silver or honey can be substantially more expensive than traditional options. Such elevated cost can limit accessibility, especially in low-resource settings where healthcare budgets are constrained and insurance coverage may be insufficient. Consequently, patients in economically disadvantaged regions or those without adequate insurance may face difficulties obtaining these advanced dressings, potentially impacting their treatment outcomes and overall market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Micro-Invasive Glaucoma Implants Market Scope

The market is segmented on the basis of procedures, implant model, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure

• Trabecular Micro-Bypass Shunt
• Hydrus Micro-Stent
• Trabectome
• Gonioscopy-Assisted Transluminal Traculomotomy
• Kahook Dual Blade
• Trab 360
• Ab-Interno Canaloplasty
• Supraciliary Microstenting

Implant Model

• Long
• Thin Tube
• Large

End-User

• Eye Hospitals
• Ophthalmology Clinics
• Outpatient Surgical Centers

Micro-Invasive Glaucoma Implants Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, procedures, implant model, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market during the forecast period, driven by key factors such as the rapidly growing elderly population and a rising incidence of glaucoma. The region's market growth is further supported by the adoption of reimbursement models for ophthalmic care and stringent regulatory measures aimed at enhancing patient safety. These developments are expected to bolster the demand for ophthalmic devices in North America.

Asia-Pacific is anticipated to experience substantial growth from 2024 to 2031, driven by increased government investment in healthcare, a large and growing population, and a surge in reported cases of blindness and cataract surgeries. Additionally, advancements in medical technology and expanding access to eye care services are expected to further boost market growth. The region's commitment to improving healthcare infrastructure and rising awareness about eye health are also contributing to the optimistic outlook.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Micro-Invasive Glaucoma Implants Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Micro-Invasive Glaucoma Implants Market Leaders Operating in the Market Are:

• Alcon (Switzerland)
• Bausch + Lomb (U.S.)
• Carl Zeiss Meditec AG (Germany)
• Johnson & Johnson Vision (U.S.)
• Lumenis Be Ltd. (Israel)
• Glaukos Corporation (U.S.)
• Lumibird Medical (France)
• IRIDEX Corporation (U.S.)
• Haag-Streit (Switzerland)
• Ziemer Ophthalmic Systems AG (Switzerland)
• Sonomed Escalon (U.S.)
• HumanOptics Holdings AG (Germany)
• BVI (U.S.)
• EssilorLuxottica (France)
• NIDEK CO., LTD. (Japan)
• Santen Pharmaceutical Co., Ltd. (Japan)

Latest Developments in Micro-Invasive Glaucoma Implants Market

• In July 2022, iSTAR Medical and AbbVie partenered to advance glaucoma treatment. This collaboration allowed AbbVie to substantially expand its portfolio of eye care products and offer glaucoma patients a broader range of treatment options.
• In January 2022, Alcon, Inc. acquired Ivantis, Inc. to enhance its portfolio of minimally invasive glaucoma surgery (MIGS) devices. By integrating Ivantis’ capabilities, Alcon seeks to expand its offerings in the glaucoma treatment market and improve patient outcomes with high-quality, minimally invasive surgical options.

SKU-36639